As a driving factor of tumor progression, TGF-β can induce tumor cell plasticity by inhibiting the anti-tumor immune response, making epithelial tumor cells more mesenchymal, stem-like and resistant to immunotherapy. The gene discussed is TGFB1; the disease is neoplasm.